Atara Biotherapeutics, Inc. (ATRA)
Every FINRA and SEC series the site collects for Atara Biotherapeutics, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.
477K
Short interest
settlement 2026-08-14
9.2
Days to cover
-11.1% vs prior
45.4%
Short share of volume
2026-09-11
1,050
Fails to deliver
settlement 2026-08-13
$959K
Insider flow, 90 days
1 buys, 1 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in ATRA is 477,268 shares, down 100,367 shares over the last month. Over the last 48 readings it ranged from 128,849 shares (15 October 2025) to 1,016,616 shares (15 January 2026). At the reported average volume of 52K shares a day that is 9.2 days to cover, elevated.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/atra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 477,268 | -11.1% | 51,842 | 9.21 |
| 2026-07-31 | 536,897 | -7.0% | 57,166 | 9.39 |
| 2026-07-15 | 577,635 | +59.8% | 92,530 | 6.24 |
| 2026-06-30 | 361,520 | -26.6% | 91,505 | 3.95 |
| 2026-06-15 | 492,405 | +1.6% | 78,554 | 6.27 |
| 2026-05-29 | 484,391 | -11.4% | 166,237 | 2.91 |
| 2026-05-15 | 546,470 | +78.5% | 7,386,437 | 1.00 |
| 2026-04-30 | 306,093 | -3.7% | 50,142 | 6.10 |
| 2026-04-15 | 317,953 | -2.8% | 77,634 | 4.10 |
| 2026-03-31 | 327,066 | +4.4% | 108,635 | 3.01 |
| 2026-03-13 | 313,290 | -5.2% | 864,901 | 1.00 |
| 2026-02-27 | 330,524 | +57.9% | 155,018 | 2.13 |
| 2026-02-13 | 209,287 | -25.9% | 87,228 | 2.40 |
| 2026-01-30 | 282,525 | -72.2% | 351,029 | 1.00 |
| 2026-01-15 | 1,016,616 | +500.8% | 1,101,087 | 1.00 |
| 2025-12-31 | 169,201 | +1.4% | 66,178 | 2.56 |
| 2025-12-15 | 166,856 | +1.3% | 82,905 | 2.01 |
| 2025-11-28 | 164,713 | -6.8% | 58,956 | 2.79 |
| 2025-11-14 | 176,777 | +4.9% | 74,588 | 2.37 |
| 2025-10-31 | 168,549 | +30.8% | 45,357 | 3.72 |
| 2025-10-15 | 128,849 | -13.9% | 61,142 | 2.11 |
| 2025-09-30 | 149,590 | -7.4% | 59,707 | 2.51 |
| 2025-09-15 | 161,507 | -7.1% | 45,951 | 3.51 |
| 2025-08-29 | 173,825 | -11.4% | 55,087 | 3.16 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of ATRA volume is 45.4%, down 37.4 points over the last five sessions. Over the last 52 readings it ranged from 3.0% (4 September 2026) to 82.8% (3 September 2026). The latest reading is 3.2 points below the 30-session average of 48.6%, on 6K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 3K | 6K | 45.4% | 0 |
| 2026-09-10 | 2K | 8K | 28.2% | 1 |
| 2026-09-09 | 13K | 37K | 34.9% | 0 |
| 2026-09-08 | 15K | 29K | 51.5% | 42 |
| 2026-09-04 | 3K | 111K | 3.0% | 0 |
| 2026-09-03 | 8K | 10K | 82.8% | 0 |
| 2026-09-02 | 3K | 5K | 56.1% | 0 |
| 2026-09-01 | 11K | 21K | 54.4% | 0 |
| 2026-08-31 | 3K | 9K | 32.7% | 0 |
| 2026-08-28 | 3K | 4K | 67.4% | 0 |
| 2026-08-27 | 3K | 9K | 38.2% | 0 |
| 2026-08-26 | 12K | 25K | 48.0% | 0 |
| 2026-08-25 | 9K | 19K | 45.9% | 0 |
| 2026-08-24 | 5K | 8K | 68.7% | 0 |
| 2026-08-21 | 2K | 10K | 18.7% | 0 |
| 2026-08-20 | 3K | 10K | 29.3% | 0 |
| 2026-08-19 | 14K | 25K | 54.4% | 0 |
| 2026-08-18 | 5K | 8K | 64.0% | 0 |
| 2026-08-17 | 21K | 28K | 73.1% | 11,663 |
| 2026-08-14 | 4K | 13K | 32.8% | 361 |
| 2026-08-13 | 11K | 39K | 29.0% | 2,754 |
| 2026-08-12 | 21K | 36K | 57.4% | 0 |
| 2026-08-11 | 7K | 9K | 80.5% | 0 |
| 2026-08-10 | 9K | 21K | 39.9% | 0 |
| 2026-08-07 | 4K | 8K | 55.9% | 0 |
| 2026-08-06 | 4K | 7K | 53.4% | 0 |
| 2026-08-05 | 7K | 12K | 57.4% | 0 |
| 2026-08-04 | 8K | 18K | 43.2% | 0 |
| 2026-08-03 | 9K | 22K | 41.7% | 0 |
| 2026-07-31 | 9K | 13K | 69.5% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 13 August 2026, the fails-to-deliver balance in ATRA is 1,050 shares, up 33 shares over the last settlement date. Over the last 52 readings it ranged from 83 shares (18 March 2026) to 33,902 shares (10 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-13 | 1,050 | $9.23 | $10K |
| 2026-08-12 | 1,017 | $8.94 | $9K |
| 2026-08-11 | 358 | $8.61 | $3K |
| 2026-08-06 | 1,748 | $8.54 | $15K |
| 2026-08-03 | 164 | $8.38 | $1K |
| 2026-07-29 | 2,312 | $7.81 | $18K |
| 2026-07-27 | 1,400 | $7.90 | $11K |
| 2026-07-24 | 1,731 | $8.17 | $14K |
| 2026-07-21 | 1,823 | $8.29 | $15K |
| 2026-07-15 | 4,081 | $8.04 | $33K |
| 2026-07-13 | 974 | $9.76 | $10K |
| 2026-07-08 | 5,649 | $10.26 | $58K |
| 2026-07-07 | 12,537 | $10.88 | $136K |
| 2026-07-02 | 11,929 | $11.37 | $136K |
| 2026-07-01 | 1,400 | $11.48 | $16K |
| 2026-06-30 | 1,000 | $11.17 | $11K |
| 2026-06-29 | 1,826 | $10.51 | $19K |
| 2026-06-26 | 7,404 | $10.22 | $76K |
| 2026-06-25 | 505 | $10.55 | $5K |
| 2026-06-23 | 1,147 | $10.61 | $12K |
| 2026-06-22 | 5,339 | $10.07 | $54K |
| 2026-06-18 | 6,788 | $9.67 | $66K |
| 2026-06-17 | 236 | $9.62 | $2K |
| 2026-06-16 | 1,142 | $9.96 | $11K |
| 2026-06-12 | 277 | $10.46 | $3K |
| 2026-06-11 | 344 | $9.86 | $3K |
| 2026-06-10 | 456 | $9.77 | $4K |
| 2026-06-09 | 612 | $9.58 | $6K |
| 2026-06-08 | 2,480 | $9.92 | $25K |
| 2026-06-02 | 1,438 | $10.28 | $15K |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days ATRA insiders reported 1 open-market buy ($1000K) against 1 sell ($41K), so the dollar flow leans toward buying. Latest filing: Cherry Brian N on 2026-09-04.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Cherry Brian N | n/a | Buy | 104K | $9.60 | $1000K | 166K |
| 2026-08-17 | Nguyen AnhCo | President and CEO | Sell | 5K | $8.08 | $41K | 133K |
| 2026-06-11 | Cherry Brian N | n/a | Grant | 24K | $0.00 | $0 | 62K |
| 2026-06-09 | HEIDEN WILLIAM K | n/a | Grant | 12K | $0.00 | $0 | 34K |
| 2026-06-09 | Fust Matthew K | n/a | Grant | 12K | $0.00 | $0 | 30K |
| 2026-06-09 | Ciongoli Gregory Austin | n/a | Grant | 12K | $0.00 | $0 | 12K |
| 2026-05-18 | Nguyen AnhCo | President and CEO | Sell | 5K | $9.13 | $48K | 138K |
| 2026-05-18 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2K | $9.13 | $22K | 50K |
| 2026-05-07 | Panacea Innovation Ltd | n/a | Sell | 313K | $10.10 | $3.2M | 1.0M |
| 2026-05-07 | EcoR1 Capital, LLC | n/a | Buy | 507K | $9.35 | $4.7M | 1.6M |
| 2026-03-17 | Panacea Innovation Ltd | n/a | Tax withholding | 5 | $5.23 | $26 | 308K |
| 2026-03-17 | Panacea Innovation Ltd | n/a | Option exercise | 259K | $0.00 | $26 | 308K |
| 2026-03-09 | Nguyen AnhCo | President and CEO | Grant | 81K | $0.00 | $0 | 143K |
| 2026-03-09 | Grant-Huerta Yanina | Chief Accounting Officer | Grant | 20K | $0.00 | $0 | 52K |
| 2026-03-02 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 100 | $5.08 | $508 | 32K |
| 2026-03-02 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 377 | $5.08 | $2K | 32K |
| 2026-03-02 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2K | $5.08 | $8K | 32K |
| 2026-03-02 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 24 | $5.08 | $122 | 34K |
| 2026-03-02 | Nguyen AnhCo | President and CEO | Sell | 1K | $5.09 | $7K | 62K |
| 2026-03-02 | Nguyen AnhCo | President and CEO | Sell | 1K | $5.09 | $7K | 63K |
| 2026-03-02 | Nguyen AnhCo | President and CEO | Sell | 58 | $5.08 | $295 | 65K |
| 2026-03-02 | Nguyen AnhCo | President and CEO | Sell | 198 | $5.08 | $1K | 65K |
| 2026-01-12 | Panacea Innovation Ltd | n/a | Sell | 81K | $6.07 | $489K | 1.3M |
| 2025-11-28 | Panacea Innovation Ltd | n/a | Tax withholding | 1 | $14.03 | $14 | 49K |
| 2025-11-28 | Panacea Innovation Ltd | n/a | Option exercise | 49K | $0.00 | $5 | 49K |
| 2025-11-17 | Nguyen AnhCo | President and CEO | Sell | 56 | $13.19 | $739 | 65K |
| 2025-11-17 | Nguyen AnhCo | President and CEO | Sell | 3K | $13.19 | $38K | 65K |
| 2025-11-17 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 74 | $13.19 | $976 | 33K |
| 2025-11-17 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 85 | $13.19 | $1K | 34K |
| 2025-11-17 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2K | $13.19 | $22K | 34K |
| 2025-08-18 | Nguyen AnhCo | President and CEO | Sell | 2K | $11.62 | $19K | 68K |
| 2025-08-18 | Nguyen AnhCo | President and CEO | Sell | 1K | $11.62 | $15K | 70K |
| 2025-08-18 | Nguyen AnhCo | President and CEO | Sell | 57 | $11.61 | $662 | 71K |
| 2025-08-18 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 2K | $11.61 | $19K | 35K |
| 2025-08-18 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 86 | $11.61 | $999 | 37K |
| 2025-08-18 | Grant-Huerta Yanina | Chief Accounting Officer | Sell | 55 | $11.61 | $638 | 37K |
| 2025-08-15 | Panacea Innovation Ltd | n/a | Buy | 55K | $12.19 | $670K | 1.4M |
| 2025-07-17 | Panacea Innovation Ltd | n/a | Buy | 19K | $9.64 | $186K | 1.4M |
| 2025-06-10 | Gallagher Carol Giltner | n/a | Grant | 8K | $0.00 | $0 | 33K |
| 2025-06-10 | Fust Matthew K | n/a | Grant | 8K | $0.00 | $0 | 18K |
| 2025-06-10 | Touchon Pascal | n/a | Grant | 8K | $0.00 | $0 | 78K |
| 2025-06-10 | Roncarolo Maria Grazia | n/a | Grant | 8K | $0.00 | $0 | 17K |
| 2025-06-10 | MALLIK AMEET | n/a | Grant | 8K | $0.00 | $0 | 17K |
| 2025-06-10 | HEIDEN WILLIAM K | n/a | Grant | 8K | $0.00 | $0 | 22K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for ATRA worth $42K at the prices reported; 1 in the last 90 days worth $42K. Latest: Nguyen AnhCo filed on 2026-08-26 to sell 5,062 shares ($42K) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-26 | Nguyen AnhCoDirector, Officer | 5K | $42K | 0.050% | 2026-08-17 | Morgan Stanley Smith Barney LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON4 holders above 5% have filed on ATRA, 4 on Schedule 13D (active intent). The largest reported stake is Redmile Group, LLC at 9.9% of the class (950,994 shares), filed 2026-07-24 for an event on 2026-07-22.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-24 | 13D/Ano. 3 | Redmile Group, LLCinvestment adviser, other entity | 951K | 9.9% | 2026-07-22 |
| 2026-07-24 | 13D/Ano. 3 | Green Jeremyindividual, parent holding company | 951K | 9.9% | 2026-07-22 |
| 2026-07-24 | 13D/Ano. 3 | Redmile Biopharma Investments II, L.P.partnership | 631K | 6.6% | 2026-07-22 |
| 2026-07-24 | 13D/Ano. 3 | Redmile Strategic Long Only Trading Sub, Ltd.corporation | 402K | 4.2% | 2026-07-22 |
13F holders
Tracked managers holding ATRA at their latest 13F. JSON3 of the 30 tracked managers held ATRA at their latest 13F, $8.2M in total at quarter-end prices. Point72 Asset Management is the largest at $7.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 688K | $7.9M | 0.01% | +493K |
| Millennium Management | 2026-06-30 | 13K | $146K | 0.00% | -35K |
| Citadel Advisors | 2026-06-30 | 10K | $117K | 0.00% | -5K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Atara Biotherapeutics, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Atara Biotherapeutics, Inc. (ATRA), SEC CIK 1604464, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-26.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-07-24.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-04.JSON and CSV
- Company record
- EDGAR filing index for CIK 1604464Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRWDCrowdStrike Holdings, Inc.
- RCGRENN Fund, Inc.
- APPAppLovin Corp
- SESea Ltd
- VICRVICOR CORP
- GOOGLAlphabet Inc.
- ANETArista Networks, Inc.
- CRMSalesforce, Inc.
- RDDTReddit, Inc.
- CRDOCredo Technology Group Holding Ltd
- NVDANVIDIA CORP
- METAMeta Platforms, Inc.
- STXSeagate Technology Holdings plc
- APPFAPPFOLIO INC
- ALABAstera Labs, Inc.
- IOTSamsara Inc.
- DASHDoorDash, Inc.
- WALWESTERN ALLIANCE BANCORPORATION
- HSYHERSHEY CO
- CPIXCUMBERLAND PHARMACEUTICALS INC
Datasets
Frequently Asked Questions
How much of ATRA is sold short?
What is ATRA's daily short volume?
Does ATRA have fails to deliver?
Are ATRA insiders buying or selling?
Have ATRA insiders filed to sell?
Who owns more than 5% of ATRA?
Which funds hold ATRA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.